nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—bone cancer	0.885	1	CbGaD
Lumiracoxib—PTGS2—Cisplatin—bone cancer	0.0511	0.746	CbGbCtD
Lumiracoxib—CYP2C9—Cisplatin—bone cancer	0.0174	0.254	CbGbCtD
Lumiracoxib—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00281	0.0741	CbGpPWpGaD
Lumiracoxib—Bromfenac—PTGS2—bone cancer	0.00226	0.278	CrCbGaD
Lumiracoxib—UGT1A9—Irinotecan Pathway—CYP3A4—bone cancer	0.00162	0.0426	CbGpPWpGaD
Lumiracoxib—Tolmetin—PTGS2—bone cancer	0.00152	0.187	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—bone cancer	0.00149	0.184	CrCbGaD
Lumiracoxib—UGT1A9—Estrogen metabolism—CYP3A4—bone cancer	0.00132	0.0349	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00119	0.0312	CbGpPWpGaD
Lumiracoxib—Mefenamic acid—PTGS2—bone cancer	0.00116	0.143	CrCbGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP4V2—bone cancer	0.00109	0.0286	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00108	0.0285	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00103	0.0272	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00103	0.0272	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000924	0.0243	CbGpPWpGaD
Lumiracoxib—Diclofenac—CYP3A4—bone cancer	0.000853	0.105	CrCbGaD
Lumiracoxib—UGT1A9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000836	0.022	CbGpPWpGaD
Lumiracoxib—Diclofenac—PTGS2—bone cancer	0.000835	0.103	CrCbGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—CDK4—bone cancer	0.000612	0.0161	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—bone cancer	0.000585	0.0154	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000585	0.0154	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000584	0.0154	CbGpPWpGaD
Lumiracoxib—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000572	0.0151	CbGpPWpGaD
Lumiracoxib—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.00055	0.0145	CbGpPWpGaD
Lumiracoxib—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000533	0.014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000522	0.0137	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000516	0.0136	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.00051	0.0134	CbGpPWpGaD
Lumiracoxib—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000502	0.0132	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000499	0.0131	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000485	0.0128	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000465	0.0122	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000465	0.0122	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000458	0.0121	CbGpPWpGaD
Lumiracoxib—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000446	0.0117	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000429	0.0113	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000398	0.0105	CbGpPWpGaD
Lumiracoxib—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000393	0.0103	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.00038	0.01	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000379	0.00997	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000376	0.00991	CbGpPWpGaD
Lumiracoxib—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000358	0.00943	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000341	0.00898	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000334	0.0088	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—GSTP1—bone cancer	0.000318	0.00838	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000318	0.00837	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000292	0.00768	CbGpPWpGaD
Lumiracoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000287	0.00755	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000251	0.00662	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00025	0.00658	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000238	0.00626	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000235	0.00618	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000235	0.00617	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	0.000234	0.00616	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000229	0.00603	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000218	0.00574	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP3A4—bone cancer	0.000218	0.00573	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000217	0.0057	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP3A4—bone cancer	0.000215	0.00565	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000214	0.00563	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GSTP1—bone cancer	0.000212	0.00559	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFBR2—bone cancer	0.000212	0.00559	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000211	0.00556	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000201	0.0053	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000196	0.00517	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000193	0.00507	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTP1—bone cancer	0.000186	0.0049	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000185	0.00487	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000184	0.00484	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—GSTP1—bone cancer	0.000184	0.00483	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000183	0.00481	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000178	0.00467	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000176	0.00462	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000156	0.00411	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000152	0.004	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000151	0.00398	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00015	0.00395	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.000146	0.00384	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000142	0.00375	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000134	0.00354	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000133	0.0035	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NDUFA12—bone cancer	0.000131	0.00344	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00013	0.00341	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000128	0.00336	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000127	0.00335	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000123	0.00325	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000122	0.00321	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDK4—bone cancer	0.000118	0.00311	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000117	0.00307	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000111	0.00292	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000108	0.00285	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NT5C3A—bone cancer	0.000108	0.00285	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NDUFA12—bone cancer	0.000106	0.0028	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000105	0.00277	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—RB1—bone cancer	0.000103	0.0027	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000102	0.00269	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000101	0.00267	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000101	0.00266	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.49e-05	0.0025	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.33e-05	0.00246	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.2e-05	0.00242	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.15e-05	0.00241	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NT5C3A—bone cancer	8.82e-05	0.00232	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.75e-05	0.0023	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.63e-05	0.00227	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NDUFA12—bone cancer	8.45e-05	0.00222	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.03e-05	0.00211	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.98e-05	0.0021	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP3A4—bone cancer	7.97e-05	0.0021	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.87e-05	0.00207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.87e-05	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—bone cancer	7.4e-05	0.00195	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.19e-05	0.00189	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.19e-05	0.00189	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NT5C3A—bone cancer	7e-05	0.00184	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.82e-05	0.0018	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.73e-05	0.00177	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NDUFA12—bone cancer	6.13e-05	0.00161	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—EGFR—bone cancer	5.98e-05	0.00157	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.96e-05	0.00157	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NDUFA12—bone cancer	5.59e-05	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.18e-05	0.00136	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NT5C3A—bone cancer	5.08e-05	0.00134	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—bone cancer	5.02e-05	0.00132	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NDUFA12—bone cancer	4.78e-05	0.00126	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ENO2—bone cancer	4.74e-05	0.00125	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NT5C3A—bone cancer	4.64e-05	0.00122	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DHFR—bone cancer	4.4e-05	0.00116	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GNA11—bone cancer	4.11e-05	0.00108	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.07e-05	0.00107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NT5C3A—bone cancer	3.96e-05	0.00104	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ENO2—bone cancer	3.86e-05	0.00102	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP3A4—bone cancer	3.72e-05	0.00098	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.71e-05	0.000975	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ENO2—bone cancer	3.66e-05	0.000964	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DHFR—bone cancer	3.58e-05	0.000943	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.42e-05	0.000899	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—DHFR—bone cancer	3.4e-05	0.000894	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GNA11—bone cancer	3.35e-05	0.000881	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTP1—bone cancer	3.18e-05	0.000838	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ENO2—bone cancer	3.07e-05	0.000807	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP3A4—bone cancer	3.04e-05	0.000799	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.02e-05	0.000795	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DHFR—bone cancer	2.84e-05	0.000749	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GNA11—bone cancer	2.66e-05	0.0007	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTP1—bone cancer	2.6e-05	0.000683	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFBR2—bone cancer	2.46e-05	0.000648	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP3A4—bone cancer	2.41e-05	0.000634	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO2—bone cancer	2.23e-05	0.000586	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DHFR—bone cancer	2.07e-05	0.000544	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—bone cancer	2.06e-05	0.000542	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO2—bone cancer	2.03e-05	0.000534	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GNA11—bone cancer	1.93e-05	0.000508	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DHFR—bone cancer	1.88e-05	0.000496	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GNA11—bone cancer	1.76e-05	0.000463	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP3A4—bone cancer	1.75e-05	0.000461	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.74e-05	0.000458	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO2—bone cancer	1.73e-05	0.000457	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KIT—bone cancer	1.68e-05	0.000442	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—bone cancer	1.65e-05	0.000434	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DHFR—bone cancer	1.61e-05	0.000424	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP3A4—bone cancer	1.6e-05	0.00042	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.59e-05	0.000418	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—bone cancer	1.58e-05	0.000415	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GNA11—bone cancer	1.5e-05	0.000396	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—bone cancer	1.5e-05	0.000394	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—bone cancer	1.36e-05	0.000359	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP3A4—bone cancer	1.36e-05	0.000359	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.36e-05	0.000357	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—bone cancer	1.35e-05	0.000354	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MDM2—bone cancer	1.32e-05	0.000348	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—bone cancer	1.17e-05	0.000307	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—bone cancer	9.04e-06	0.000238	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—bone cancer	7.76e-06	0.000204	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—bone cancer	7.07e-06	0.000186	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—bone cancer	6.04e-06	0.000159	CbGpPWpGaD
